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ABSTRACT
by
Mihaela Ciulei
Global DNA Methylation (GDM), an epigenomic modification has been linked to the
development of cardiovascular disease and its risk factors. Our focus was to identify potential
relationships between epigenetic alterations and both cardiovascular fitness and body
composition measures. Purpose: As increases in aerobic fitness have a beneficial effect on
cardiovascular disease, one purpose was to determine if a relationship was evident between
global DNA methylation and VO2max. A secondary purpose was to determine if the
relationship extends to body composition measured via Dual X-ray Absorbtometry (DXA).
Methods: Fifty-two (male n=25, female n=27) subjects provided a blood sample for DNA
isolation, underwent a DXA scan, and completed a maximal exertion exercise test on a
treadmill for the determination of maximal aerobic capacity (VO2max). Global DNA
methylation (GDM) (%) was evaluated utilizing a commercially available ELISA kit, and
correlated with BMI, percent body fat (%BF), and VO2max using Pearson’s correlation
coefficient with significance accepted at p≤0.05. Participants were divided into high and low
groups according to median score and differences were determined by the independent t-test.
Results: When the overall group was considered, GDM was not significantly correlated with
any measure (BMI r=-0.15, p=0.27; %BF r=-0.20, p=0.14; VO2max r=0.24, p=0.09). When
separated by gender, males displayed no significant correlations for any variable. In females,
GDM was significantly correlated with BMI (r=-0.38, p=0.05), % BF (r=-0.43, p=0.02), and
VO2max (r=0.39, p=0.04). Also, when the t-test was preformed there were no differences in
the whole group or in the female group, but there were differences in the male group for %BF
(p=0.007) and BMI (p=0.028). Conclusion: The results provide evidence that as BMI and %
body fat increases, GDM decreases in females when they were tested for a relationship. In
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addition, epigenetic modifications appear to be associated with aerobic fitness in women.
Future research should be directed toward identifying the gender difference observed from this
data. The men in this study had significantly lower body fat (21±9 vs 29±8%) and greater
VO2max (54±10 vs 46±9 ml/kg/min) compared to the women. Upon examining the data via
the t-test in men, our results show that greater %GDM are found in the lower groups for %BF
and BMI. It is possible that epigenomic effects are associated with a threshold of body fatness,
and future studies should investigate this possibility.
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INTRODUCTION
Cardiovascular diseases (CVD) is one of the most prevalent deaths in the U.S. as well as
worldwide. In the U.S. alone 179.1 deaths were reported in 2010 per 100,000 population (5). This is
one-third of all U.S deaths (5). Financially, CVD impacts the U.S. by approximately $444 billion.
This number is expected to increase since the U.S. population ages (5). Global DNA Methylation
(GDM), an epigenomic modification has been linked to the development of cardiovascular disease
and its risk factors. Thus, it seems appropriate to determine if there is a relationship between
cardiovascular fitness level and the level of Global DNA Methylation (GDM). GDM is an epigenetic
modification that occurs in the human genome and it is essential for regulatory and developmental
processes (28). The indicator for the cardiovascular fitness level used is the maximal oxygen
consumption.
The field that studies the 3 billion base pair long chain of genetic information is known as
genomics. The human genome is incredibly complex and was first elucidated in 2003. Since then this
field has expanded tremendously. The field of epigenomics explores the external factors that humans
choose to do that affect the great variety phenotypes in the human genome (19, 21).
Epigenomics is the study of heritable genome alterations in gene expression potential that are
not caused by changes in the actual DNA sequence (23). These alterations to the genome result in
differences to the future outcome or expression of the genetic information. Today there are three main
mechanisms that contribute to epigenomic alterations: 1) DNA methylation, considered the primary
measure, 2) histone modification, and 3) autoregulatory proteins that add in modification (23).
A great deal of research has been conducted on the effects of DNA methylation on health
issues since the early 2000s, however most of this research has been focused on the links to cancer (7,
8). The more recent research such as the study published by Kim et al. (7) has tried to find a
biomarker such as the DNA methylation to identify the CVD. So far CVD risks have been shown to
link with DNA methylation: obesity, smoking, and nutritional status (15). Furthermore, Breton et al.
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(3) observed that children who were prenatally exposed to smoking, had significantly (p=0.03) lower
methylation levels at the AluYb8 gene. Methylation of this gene is correlated with birth weight
percentile therefore lower levels of methylation are not desirable because these children may be more
prone to CVD.
Not all risk factors for CVD have been investigated thoroughly so far. The least investigated is
the relationship between physical inactivity and/or exercise and DNA methylation. A simple search on
PubMed revealed that 1,235 articles have been published on DNA methylation and exercise, whereas
the number of published articles concerning DNA methylation and obesity, or DNA methylation and
nutrition are two to four times more. Considering this, it is a good approach to research the
relationship between obesity, smoking, and nutritional status. The results of this analysis could
provide evidence that the DNA methylation biomarker can be considered for CVD and its risk factors.
This study will contribute to the field of genomics if it reveals a connection between
cardiovascular fitness level, body mass composition, and the biomarker GDM. If significant
connections are found between the variables chosen then the GDM biomarker would be a valuable
identifier of the quantitative risk factor for cardiovascular diseases.
As previously mentioned, PubMed search results show the number of publications that discuss
DNA methylation and its relationship with cardiovascular disease is very limited. However, there is
some evidence in regards to the relationships between the epigenomic markers in relationship with
cardiovascular disease. The rest of this paper discusses these findings including the different types of
epigenomic markers, the correlation between DNA methylation and CVD, the relationship between
DNA methylation and obesity, and the influence of exercise on DNA methylation.
Purpose of the Study
The purpose of this study is to determine if there is a correlation between cardiovascular fitness
level, as determined by maximal oxygen consumption, and level of global DNA methylation.
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Additionally, the study will investigate the relationship between percent body fat and Global DNA
methylation.
Research Hypotheses
Hypothesis #1
H01: There will be no correlation between cardiovascular performance measures and global DNA
methylation level.
HA1: There will be a correlation between cardiovascular performance measures and global DNA
methylation level obtained from isolated white blood cells.
Hypothesis #2
H02: There will be no correlation between body composition and global DNA methylation level.
HA2: There will be a correlation between body composition measures and global DNA methylation
level obtained from isolated white blood cells.

LITERATURE REVIEW:
Epigenomic Markers
DNA methylation, histone modification, and autoregulatory proteins that cause modification
are the three mechanisms responsible for epigenetic and epigenomic modifications (25). DNA
methylation has been utilized as an indicator in the most up to date literature. The reason for using it is
because DNA methylation is a commonly used tool that can test both at the genetic and genomic
level, and because DNA methylation is effected by histone modification and autoregulation. The
following information illustrates briefly how these epigenomic mechanism works.
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DNA Methylation
As illustrated in Figure 1, the process of DNA methylation involves the addition of a methyl
group to a CpG dinucleotide within the genome.

Figure 1: DNA Methylation at CpG Dinucleotide (7)
Baccarelli & Ghosh (1) describe the whole DNA methylation process, which begins with the action of
four enzymes collectively known as DNA methyl transferase. One of the DNA methyl transferase
enzymes interacts with S-adenosylethionine (SAM) and accepts a single methyl group from SAM,
converting SAM into S-adenosylhomocysteine (SAH) (see Figure 2). Next, the free methyl group is
attached to the 5th position on a CpG dinucleotide, hence the red color coded CH3 (CpG island).

Figure 2: CpG Methylation (10)
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The position where the process of methylation occurs in the genome is very important because
it can occur anywhere within the CpG island. The position controls the effect of the methyl group in
the genome. For instance, the transcription of a gene can be repressed if the CpG island is located
within the coding or promoter region. However, this process occurs very rarely, only 10% of all
methylated CpG islands are found within a coding region (1).
Why the process of methylation occurs is not well understood, however some research has
shown a correlation between methylation levels and health complications including atherosclerosis
and certain cancers (8). Diet and exercise habits have been correlated hyper or hypo levels of
methylation (8). The trends and relationships of hyper and hypo levels of methylation is discussed
below.
Histone Modification
Another epigenetic marker used is histone modification. Histones are proteins that are
surrounded by 146 base pairs of DNA. Four main proteins make up the histone (H2A, H2B, H3, and
H4) and an unstructured N-terminal tail (13). Histones help DNA package into nucleosomes that can
form a chromosome. In order for the histone to be modified one of the following processes needs to
occur at the N-terminal tail: methylation, acetylation, phosphorylation, ubiquitination, biotinylation,
sumoylation, and proline isomerization. These alterations at the N-terminal tail are known as the
histone mark. Alterations at the histone mark can cause gene repression or silencing by adjusting
expression of that part of the DNA strand around the histone (see Figure 3).
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Figure 3: Histone Modification Causing Gene Silencing
Courtesy of the National Human Genome Research Institute

DNA Methylation and Cardiovascular Disease
DNA methylation is important especially when correlated with diseases. Historically, DNA
methylation was primarily used in cancer and tumor development, but recently it has been used in
cardiovascular diseases to indicate the risks and the stages of development. These relationships were
first identified in animal studies. Lundi et al. (2004) conducted a study in mice to elucidate the DNA
methylation patterns in mice without apolipoprotein E (apoE) versus a control group (12). The results
showed that the apoE group was more likely to develop atherosclerosis whereas the control group
contained the unaffected/normal mice. These two groups were observed for a period of six months. A
DNA fingerprinting procedure was used to analyze the level of DNA methylation in these two groups.
At four weeks blood analysis did not show any significant difference in DNA methylation patterns
between the two groups. However, aorta tissue samples from the apoE- mice were found to have
significantly different (p<0.04) methylation patterns compared to the control group. These patterns
9

consisted of both hyper and hypomethylation. However, when samples were collected after 6 months,
both the blood and aorta tissue samples indicated a significant difference between the apoE and
control group: (p<0.02, p<0.003 respectively). These patterns were the hyper and hypomethylation
levels in the apoE group. Furthermore, in the apoE group it was the fibrocellular lesions which
indicate the development of atherosclerosis. Although the results were somewhat inconclusive as to
how atherosclerosis causes modifications in GDM, they do show that GDM is significantly altered
with the development of atherosclerosis (12).
In 2007, Stevinkel et al. (23), came up with a similar approach as Lundi et al. (12) but their
work was done on human subjects. Stevinkel et al. (23) identified the link between DNA methylation
and cardiovascular disease development in chronic kidney disease (CKD) patients who have a higher
risk of cardiovascular disease, and a control group. The control and the CKD group were monitored
for the elevated GDM levels (by collecting blood samples) and the symptoms of cardiovascular
diseases (by analyzing the inflammation and oxidative stress biomarkers for a period of 36 months.
The results revealed that the patients with CKD and inflammation had higher levels of methylation
(p< 0.001) and those who did not have inflammation had results similar to those in the control group.
This study concluded that patients that were developing cardiovascular diseases presented elevated
levels of methylation or hypermethylation (23).
Another study came out three years later showing important aspects of the levels of
methylation in a population based study. Kim et al. (9) used a similar approach as Stevinkel et al. (23).
The levels of DNA methylation and the cardiovascular disease level were assessed in 286 males and
females out of a population (N=63,257) based cohort in Singapore over a five year period. At the
beginning of the study, 101 subjects were identified with cardiovascular disease. Then, at the second
meeting, another 52 subjects of the remaining 185 were identified with cardiovascular disease.
Subjects with (n=153) and without (n=133) cardiovascular had their DNA methylation levels
analyzed. Although, the results obtained did not indicate significant difference for this population, the
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results were further analyzed after the samples analyzed based on differences in gender. A higher
level of GDM (p<0.05) was identified in males with cardiovascular disease versus those who did not
have cardiovascular disease. However, in females the results were not significantly different. These
results were consistent with Stenvinkel et al. (23). Table 1 below shows the results.
Table 1. Summary of DNA Methylation and Disease Research

Article

Subjects

Dependent

Independent

Variable

Variable/s

Lundi et al.

Results

Prevalence of
n=27 mice

↑ GDM

GDM

(2004)

atherosclerosis

n=191

Inflammation
↑ GDM in patients

Stenvinkel et al.
males &

GDM

measured by IL-6

(2007)

with inflammation
females

and C

n=286
↑ GDM in CVD

Kim et al.
males &

GDM

CVD

(2010)

patients
females



GDM = Global DNA Methylation



CVD = Cardiovascular Disease



IL-6=Interleukin 6



C=C-reactive protein
DNA Methylation and Obesity
Recently, it has been shown that GDM may be closely correlated with obesity via the body

mass index indicator (9). The researchers looked at 286 men and women from Singapore and
discovered that those with a body mass index (BMI) value of 24 kg/m2 or higher had significantly (p
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= 0.007) elevated levels of GDM than those with a BMI value lower than 24 kg/m2. Furthermore,
Wang et al. (28) and Milagro et al. (16) found consistent results with Kim et al. (9) in which the
methylation status of individual genes were examined. Similarly, Milagro et al. (16) found that
overweight/obese individuals had elevated methylation levels of the circadian clock system (internal
clock) gene, CLOCK 1, compared to lean individuals (17.4% compared to 12.4% respectively).
Though evidence displayed above gives insight to the relationship between obesity and DNA
methylation levels, it does not take individual’s percentage of fat mass into consideration. All three of
the aforementioned studies used BMI as their stratification tool for obesity, there by not actually
measuring the amount of fat mass or fat-free mass. One study looked at whether methylation levels
could be used to indicate weight loss and body composition to a hypocaloric diet measured body
composition with the bioelectric impedance analysis and not by BMI (16). Milagro et al. (16) set out
to determine whether methylation levels of nine obesity-related genes (AQP9, ATP10A, CD44, IFNG,
MEG3, NTF3, POR, TNFRS9, and WT1) in order to determine the weight loss and body composition
responses to a hypocaloric diet. The study of twenty-five (n=25) overweight or obese (BMI M (SD):
30.5 (0.45) kg/m2)) men tracked height, weight, age, percent body fat, waist girth, and blood levels
prior to and following an eight week hypocaloric diet. The DNA methylation levels were assessed by
peripheral blood mononuclear cells. Their results help us consider two relative concepts: 1) DNA
methylation at a genetic level is significantly correlated with changes in fat mass, over-all weight, and
changes in waist girth, and 2) DNA methylation (ATP10A and CD44 genes specifically) can be used
to predict an individual’s degree of response to a hypocaloric diet.
Although Milagro et al. (16) did not investigate the GDM alteration with weight or fat loss,
their data illustrates the correlation between DNA methylation and obesity and it is consistent with the
other sources mentioned above (9, 23, 17,19).Moreover, it provides evidence of using DNA
methylation as an indicator of CVD risk factors and responses to lifestyle changes.
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DNA Methylation and Exercise
The relationship between DNA methylation and exercise has not been examined in great
detail. Recent database searches have yielded minimal findings, resulting in only a hand full of
articles pertaining to the topic. Additionally, the available findings are contradictory with reports of
both increasing and decreasing in methylation levels.
Zhang et al. (27) examined the relationship between physical activity levels of cancer-free
adults (ages 45-75 years old) and their GDM level. A baseline blood sample was taken from each
participant at the beginning of the study and they wore accelerometers for 4 days (3 weekdays and 1
weekend day) to determine their level of physical activity. It was observed that individuals that were
physically active for 26-30 minutes per day had significantly higher levels of GDM compared to those
who were active for less than 10 minutes per day (β = 2.52, 95% CI: 0.70, 4.35). Simple linear
regression was not significant, negating the idea of a dose-response relationship between the two
variables. These findings suggest that individuals that achieve the recommended amount of physical
activity per day are hypermethylated compared to sedentary individuals (27).
While the above mentioned study demonstrated an elevated level of methylation on a genomic
level, results from Barres and associates (2) revealed differences on a genomic as well as a genetic or
per gene basis. Barres et al. (2) examined the acute effects of a single bout of exercise on DNA
methylation levels in healthy, sedentary men and women (n=14). Blood samples were taken before
and after a peak pulmonary oxygen uptake rate test on a magnetically braked cycle ergometer. The
results of a paired t-test showed a significant (p < 0.05) decrease in GDM after exercise. Additionally,
individual genes associated with metabolic and structural functions in skeletal muscles (PGC-1a,
TFAM, PPAR-d, PDK4, citrate synthase [CS]) were examined and found to have decreased
methylation levels following the cycle test. These results seem to contradict the hypermethylation
findings of Zhang et al. (27).
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To further investigate the effects of acute exercise on DNA methylation, Barres et al. (2)
looked at a subgroup (n=8) of the original 14 participants and had them complete two additional
exercise sessions in the following days after the VO2max tests. (The VO2max test measures the volume
of oxygen that one individual can consume while exercising at his/her maximum capacity. VO2 max is
the maximum amount of oxygen in millilitres, one can use in one minute per kilogram of body weight.
Those who are fit have higher VO2max values and can exercise more intensely than those who are not
as well conditioned). In the study conducted by Barres et al. (2), the additional exercise sessions were
completed on separate days with at least one week in between the trials. Each exercise session was
conducted on the same cycle ergometer at varying intensities (40% or 80% of aerobic capacity).
Blood samples after each exercise session were evaluated for changes in DNA methylation of the
previously mentioned genes. It was found that low intensity (40% aerobic capacity) exercise did not
alter methylation levels compared to resting values, while high intensity (80% aerobic capacity)
exercise decreased methylation values (p < 0.05). These results are again contradictory to Zhang et al.
(27) and suggest that a dose response relationship may exist between exercise and gene methylation
levels (2).
Though GDM was not measured, Nakajima et al. (19) shows that exercise induced
hypermethylation of the ASC (Apoptosis-associated Speck-like protein containing a Caspase
recruitment domain) gene in older men. The research group set out to evaluate the effects of chronic
exercise on the methylation levels of the ASC gene that is responsible for the production of proinflammatory cytokines. A total of 383 older (40-87 years of age) males were divided into either an
exercise (n = 230) or a control (n = 153) group. The exercise group completed bouts of high-intensity
interval walking (3 minutes of 40% peak aerobic capacity followed immediately by 3 minutes of
walking at 70% peak aerobic capacity) every day for 6 months. Blood samples were taken at the
completion of the 6 months and tested for methylation of the ASC gene. The exercise group had
significantly (p<0.01) higher methylation values for the ASC gene compared to the control group.
14

This led the researchers to conclude that exercise induces hypermethylation of the ASC gene in older
males thereby decreasing the production of pro-inflammatory cytokines (19).
The primary objective of this study is to determine if there is a correlation between body
composition measures, cardiovascular performance measures, and GDM level obtained from isolated
white blood cells.

METHODOLOGY
Participant characteristics
Based on what participants answered in the Modified American College of Sports Medicine
Health/Fitness Facility Pre-participation Screening Questionnaire all subjects were appearing healthy.
This was defined after they received a passing score in the questionnaire. The sample size consisted of
fifty-two subjects (male n=25, female n=27) with ages ranging from 18 to 44. The height, weight, and
age average and standard deviations are shown below.
Table 2. Participant Characteristics
N
Height (cm)
Weight (kg)
Age (years)

Males

Females

25
179 ± 9.4
83.9 ± 14.5
27.4 ± 7.6

27
163.2 ± 5.7
59.4 ± 7.4
26.8 ± 5.4

Collection of the Data
Preliminary Data
Each subject was informed to come appropriately dressed (running attire) prior to the VO2max
testing and dual energy x-ray absorptiometry (DEXA) scan. Subjects were instructed to be very well
hydrated and not eat two hours before the test, no alcohol or caffeine nor exercising for at least 6-24
hours prior to being tested.
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Before testing, each individual had to sign an informed consent document that explains the
purpose, requirements, procedures, risks, and benefits of the study. This document was approved by
the UNLV Institutional Review Board (Protocol #: 1209-4268). The subjects also completed the
Modified American College of Sports Medicine Health/Fitness Facility Pre-participation Screening
Questionnaire. Only those who passed the health questionnaire entered the study. Next, each subject
was assigned an identification number and their height, weight, and age was taken. Then, using
DEXA, body composition was determined.

Graded Exercise Test
Participants completed a graded exercise test (GXT). The GXT was conducted on a treadmill
using two minute stages. The participants walked at a self-selected speed with no incline for two
minutes, followed by jogging for two minutes at a self-selected speed with no incline. The incline of
the treadmill was increase by 2% grade every two minutes while remaining at the same jogging speed,
until volitional fatigue. Before beginning the GXT, the participants were instructed on how to use the
Borg Ratings of Perceived Exertion scale (RPE). The GXT was terminated when the participant
could no longer continue or if the participants wished to stop. Heart rate and oxygen uptake were
measured continuously throughout the test by a Moxus Metabolic System (AEI Technologies,
Pittsburgh, PA). The participant’s RPE score was evaluated at the end of every stage. Participants’
VO2max values were determined by averaging the two highest, consecutive values in a 30 second
rolling average of VO2 (ml/kg/min). The time period used for the rolling average was defined as the
period in which the participant had achieved two of the following criteria: heart rate ≥ 90% of their
age predicted max, a respiratory exchange ratio at or above 1.05, an RPE ≥ 19, or their VO2
(ml/kg/min) value had plateaued despite an increase in exercise intensity.
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Blood Sample Collection
A sample of blood (600 µl) was collected via finger-sick using aseptic technique into an
anticoagulant tube (Multivette 600 LH, Sarstedt, Fisher Scientific, Pittsburgh, PA). The anatomical
site of the blood draw was cleaned with an alcohol swab prior to all blood draws. Samples were
labeled with corresponding subject identification numbers before being placed in a sealed and labeled
biohazard bag (primary container) inside of a sealed and labeled biohazard cooler (secondary
container). Samples were kept in an ice bath until analyzed in accordance with the parameters
described in the University of Nevada, Las Vegas Institutional Biosafety Manual (Section VIII, page
19). Standard biological personal safety barriers including latex-free gloves, laboratory coat, and eye
safety goggles were worn at all times by members of the research team. All sharps and biological
materials were disposed off in labeled and sealed sharps container and decontamination was
conducted in accordance with the University of Nevada, Las Vegas Institutional Biosafety Manual
(Section IX, page 23).

Blood Sample Analysis
Each sample was transported to the Exercise Biochemistry Laboratory for DNA isolation and
storage. Whole blood (approximately 300 µl) was added to 900 µl of Cell Lysis Solution, thoroughly
mixed, and incubated for 10 minutes at room temperature. The sample was centrifuged, and the
supernatant discarded without disturbing the white blood cell pellet. The cells were then re-suspended
via vigorous vortexing and 300 µl Nuclei Lysis Solution was added and it was pipetted 5-6 times to
lyse the white blood cells. At this point the solution appeared very viscous. Next, 100 µl of Protein
Precipitation Solution was added, vortexed, and then centrifuged. A dark brown protein pellet was
visible at the bottom of the tube, and the remaining supernatant was transferred to a new
microcentrifuge tube containing 300 µl room temperature isopropanol. This tube was gently mixed
and then centrifuged to pellet the DNA. The supernatant was discarded in a biohazard waste container,
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and equal volume of 70% ethanol was added in a wash step before centrifugation. The tube was
inverted over absorbent paper and allowed to air-dry for 15 minutes. DNA Rehydration Solution (20100 µL) was added to the tube and allowed to incubate overnight at room temperature before being
stored at 2-8 ºC for subsequent epigenetic analysis. DNA concentration (ng/mL) was determined using
an Epoch microplate reader with the Take3 System (Biotek U.S., Winooski, VT).
After all samples were collected via the method explained above, the level of GDM was
determined. This was done by using the commercially available assay kit (MethyFlash Methylated
DNA Quantification Kit, Epigentek Group Inc., Farmingdale, NY). A binding solution, followed by
the samples was added to an antibody-infused 96 well plate. Negative and positive controls, as well
as diluted positive values were added alongside the samples and tested in order to produce a standard
curve for quantification proposes. Then, the samples were incubated for 90 minutes inside the wells.
Next, the samples were removed and the wells were washed with a wash buffer and a capture
antibody was added to each well. The plate was incubated for 60 minutes. The removal of the solution
and the washing procedure with the buffer was repeated for cleaning purposes. After the second wash,
a detection antibody was added and the wells were incubated for 30 minutes. An enhancer solution
was added to each well and a final 30 minute incubation phase followed. The wells were washed for
the last time and the developer solution was added giving the sample a bluish color based on the
methylation level. Finally, a stop solution was added to all wells in order to control the reaction
(which one??) and have it run for only a specific amount of time. Next, the 96-well microtiter plate
was placed in a microplate reader and analyzed at 450 nm. All samples were processed at the same
time and GDM levels were expressed as an absolute percentage based on the determined standard
curve. The formulas used were given below.
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S stands for the concentration of sample DNA used in nano grams (ng). OD stands for optical
density (basically it’s an indicator of the amount of color displayed; the darker the blue, the greater the
concentration).

Data Analysis Methods
A Pearson product-moment correlation coefficient (Pearson’s “r”) was used to determine the
correlations between body composition, fitness measurements, and GDM percentage. A series of ttests were conducted to determine any underlying differences for the whole group as well as for each
gender. High and low value groups from each variable were constructed and compared for significant
differences. The groups were determined by whether they are higher or lower than the median for
each variable. In case a subject fall on the median, then the value will be compared with the standard
for that specific variable and a decision will be made whether that value will be in the lower or higher
group. The significance level was set at α = 0.05. All statistical analyses were calculated using SPSS
Version 20 (IBM Corporation, Armonk, NY).

RESULTS
Correlations
A total of four different measures (percent body fat, body mass index, bone mineral density,
VO2max [ml/kg/min]) were examined for a relationship with GDM percentage. The overall group was
first analyzed for correlations and then each gender was analyzed separately. When the overall group
was considered, GDM was not significantly correlated with any measure (BMI r=-0.15, p=0.29; %BF
r=-0.2, p=0.13; VO2max r=0.39, p=0.07).When separated by gender, males displayed no significant
correlations for any of the variables. However, in females, GDM was significantly correlated with
BMI (r=-0.38, p=0.05), % BF (r=-0.43, p=0.02), and VO2max (r=0.39, p=0.04).
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Table 3. Correlation Results
Pearson's r p-value
Name of Variable
Total Group
Body Fat
-0.2
0.137
BMI
-0.38
0.256
BMD
0.24
0.686
VO2max
0.39
0.089
Males
Body Fat
0.107
0.409
BMI
-0.166
0.508
BMD
0.269
0.269
VO2max
0.18
0.180
Females
Body Fat
0.128
0.022*
BMI
-0.431
0.047*
BMD
0.394
0.515
VO2max
-0.085
0.042*
*% BF, BMI, and VO2max were significantly correlated to GDM in
Females.

t-tests
To further investigate the possibility of a relationship between GDM percentage and the
aforementioned variables, t-tests were conducted for potential differences between high scores verses
lower values for any given variable. The analysis was done for the whole pool of subjects as well as
for each gender. When the whole group of subjects was considered, the median values were:
percentage of body fat (24.10%), body mass index (23.4 kg/m2), bone mineral density (1.209 g/cm2),
VO2max (50.1 ml/kg/min); subjects were grouped according to whether they were higher or lower than
the median value for each variable. The t-tests revealed a significant difference in the percentage of
GDM between those with higher VO2max values compared to those with lower levels (see Table 3.A).
The difference in GDM% when compared to the high and low groups for body mass index, bone
mineral density, and percentage of body fat revealed no significance. When the groups were divided
by gender and analyzed in the same fashion only the males group showed significant results in percent

20

body fat and body mass index when compared to percentages of GDM (see Table 3.B). The females
group showed no difference for any of the variables (see Table 3.C).

Table 3.A t-test results for the whole group
Median
Mean
32.50%
BF%
24.10%
17.60%

Group
SD
1.40%
4.50%

High
Low

Methylation (%)
Mean
SD
1.4
1.4
1.9
1.2

p value
0.13

BMI

23.4

27.4
21

3.9
1.4

High
Low

1.5
1.9

1.1
1.4

0.29

BMD

1.209 (g/cm2 )

1.33
1.15

0.08
0.05

High
Low

1.6
1.8

1.2
1.4

0.58

VO2max

50.1 (ml/kg/min)

58.4
41.9

6.4
6.1

High
Low

2.1
1.4

1.4
1.2

0.07

Table 3.B t-test results for the male group
Median
Mean
SD
35.20%
6.40%
BF% 26.10%
22.10%
2.80%
BMI

21.8

BMD 1.158 (g/cm2 )

Group
High
Low

Methylation (%)
Mean
SD
1.2
0.8
2.6
1.5

p value
0.007*

24.4
20.5

1.7
1.1

High
Low

1.3
2.5

1
1.5

0.028*

1.21
1.11

0.05
0.04

High
Low

2.1
1.7

1.6
1.2

0.54

2.4
1.5
53.4
7
High
1.6
1.1
39.5
6.4
Low
*The % BF has significant differences in % GDM between the high and the low groups
* The BMI has significant differences in % GDM between the high and the low groups
VO2max
45.9 (ml/kg/min)

21

0.14

Table 3.C t-test results for the female group
Median
Mean
SD
28.70%
6.60%
BF%
18.70%
14.20%
3.60%

High
Low

Methylation (%)
Mean
SD
1.5
1.3
1.3
1.1

Group

p value
0.78

BMI

25.2

29.7
23.4

4.2
1

High
Low

1.73
1.06

1.27
1.07

0.15

BMD

1.326 (g/cm2 )

1.4
1.24

0.05
0.05

High
Low

1.5
1.3

1.3
1.1

0.8

61.8
46.4

5
6.2

High
Low

1.6
1.4

1.1
1.4

0.76

VO2max 53.7 (ml/kg/min)

SUMMARY, CONCLUSIONS, AND RECOMMENDATIONS
Discussion of Results
Since an increase in aerobic fitness have a beneficial effect on cardiovascular disease, the first
purpose of this investigation was to determine whether a relationship exists between the percentage of
global DNA methylation and measures of aerobic fitness (via VO2max). The second purpose was to
determine if a relationship extends to measures of body composition (via Dual X-ray Absorbtometry
(DXA)). It was hypothesized that a significant correlation would exist between GDM% and measures
of aerobic fitness and body composition. Upon experimentation the association between VO2max and
GDM%, was proved as being not significant. Thus, for the overall group, we retain the null
hypothesis. When considering the body composition measure, the percentage of body fat measure, and
the aerobic fitness measure, we found that a significant relationship existed with global DNA
methylation percentage in the female group only. Thus, we accept the alternate hypothesis with regard
to BMI, % BF, and VO2max.
Upon classifying the subjects by gender, it was determined that there was a negative
correlation with BMI and percent body fat when compared with GDM percentage in females. The
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results provide evidence that as BMI and % body fat increases, GDM decreases in females. These
results disagree with the findings of Kim et al. (7) in two ways. First, the association found in this
study suggests that as BMI increases, GDM percentage decreases, while Kim et al. (7) found the
opposite. Secondly, both males and females displayed a significant correlation in the Kim et al. (7)
study while only females did so presently. These disagreements are due to the fact that the Kim et al.
(7) study was conducted in Singapore, where the obesity rate is much lower than in the United States
(12% versus 36% respectively) and the fact that the present study had a much smaller sample size
(n=52 vs n=286 comparatively). The population groups are also different as well as their diets.
Furthermore, epigenetic modifications appear to be associated with aerobic fitness in women. Future
research should be directed toward identifying the gender difference observed from this data. The men
in this study had significantly lower body fat (21±9 vs 29±8%) and greater VO2max (54±10 vs 46±9
ml/kg/min) compared to the women. These data indicate that % body fat is an important variable and
it is inversely related with VO2max. It is possible that epigenetic effects are more evident in a
population with reduced overall fitness parameters. This study was also unique in that it took an
actual measurement of body composition (DEXA scan), as well as calculating BMI values.
Additionally, Kim et al. (7) reported that global DNA methylation was significantly associated
with an increased risk of cardiovascular disease. Specifically, they reported that males who developed
cardiovascular disease (myocardial infarction, stroke) or its predisposing conditions (hypertension and
diabetes) over a 5 year span had significantly higher levels of GDM compared to their disease free
counterparts (p=0.03). As it is well established that physical fitness level and aerobic capacity is
inversely related with cardiovascular disease risk, it seemed intuitive that a measure of aerobic
capacity (VO2max) would also be related to global DNA methylation (8, 19). We found that VO2max
was significantly (r =0.20, p=0.14) related to GDM percentage in females but not in males. Since the
results provide evidence that as BMI and % body fat increases, GDM decreases in females only. In
addition, epigenetic modifications appear to be associated with aerobic fitness in women. Future
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research should be directed toward identifying the gender difference observed from this data. The men
in this study had significantly lower body fat (21±9 vs 29±8%) and greater VO2max (54±10 vs 46±9
ml/kg/min) compared to the women.
However, when the independent t-test was performed, after the participants were divided into
high and low groups according to median score, we observed differences in the male group only for %
BF (p=0.007) and BMI (p=0.028). The % GDM was greater in the lower groups for these two
variables. Nonetheless, there was no significant (p=0.14) difference between the high or low VO2max
groups as we would have thought. However, the males’ %BF is normal (35.2% in the high group) and
the VO2max is high (53.4 in the high group) compared to the females’ %BF that is very low (28.7% in
the high group) and the VO2max is very high (61.8 in the high group). It is possible that epigenomic
effects are associated with a threshold of body fatness, therefore % body fatness is a key factor and
future studies should investigate this possibility.
It is possible that epigenetic effects are more evident in a population with reduced overall
fitness parameters. While cardiovascular disease risk is positively impacted by one’s aerobic fitness,
there are confounding factors that may affect the cardiovascular system, including smoking, dietary
habits, and family history. Further research is necessary to determine whether other measures of
aerobic fitness are more sensitive correlates with DNA methylation.

Conclusions and Recommendations for Further Study
Most methylation studies, be them GDM or individual gene methylation studies, have subject
pools numbering in the hundreds due to the innate variance in individual genomes.

As trends were

evident with the small number of subjects in the present investigation, continued studies with a more
diverse sample are warranted. A future study should be considered in evaluation the levels of DNA
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methylation in a group with sedentary or less physically fit women subjects versus physically fit, or
athletic women. This way we would be able to test the results found in this study and we may see
stronger correlations. Furthermore, instead of dividing the groups by their median score, it would be
better to partition the groups based on a set threshold level such as a BMI greater than 25.
In addition to the pervious comment, it should be noted that at present time, there is no
standard order or procedure for reporting GDM percentages. The current study has an average GDM
percentage of 2.7% which is similar to the findings displayed by McGuinness et al. (14). At the same
time, GDM percentages have been published ranging from 0.85% (11) to 91% (4). This large
discrepancy could be due to the fact that various means of DNA isolation and GDM quantification
were used by the studies, which has been shown to significantly affect the GDM percentages (21).
This lack of standardization does not allow for easy comparisons between studies and can be very
misleading when examining multiple studies. Standardized measurements need to be established in
order for future research to prosper.
To our knowledge, this is the first study to correlate a direct measure of body composition with
GDM. While the small number of subjects was a serious limiting factor, a number of interesting
findings were present. It was demonstrated that an inverse relationship between GDM and BMI and
% BF appears to be present in females, while not in males. At this time, it does not appear that there
is a relationship between cardiovascular fitness, measured by VO2max, and GDM. Additionally,
studies with further measures of aerobic fitness and greater numbers of subjects are needed in order to
definitively say that this relationship does not exist. Also, new studies should be conducted in order to
test the gender differences that were noticed in this study since the males in this group had a lower
body fat percentage as well as greater VO2max when compared with the females group. DNA
methylation continues to be a biomarker of great importance in terms of detecting cardiovascular
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disease risk and prevention. Its effects may be more obvious in a pool of subjects with reduced overall
fitness parameters.
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TABLES
Table 1. Participant Characteristics
Males

Females

n

25

27

Height (cm)

179 ± 9.4

163.2 ± 5.7

Weight (kg)

83.9 ± 14.5

59.4 ± 7.4

Age (years)

27.4 ± 7.6

26.8 ± 5.4

Table 3.A t-test results for the whole group
Median
Mean
32.50%
BF%
24.10%
17.60%

Group
SD
1.40%
4.50%

High
Low

Methylation (%)
Mean
SD
1.4
1.4
1.9
1.2

p value
0.13

BMI

23.4

27.4
21

3.9
1.4

High
Low

1.5
1.9

1.1
1.4

0.29

BMD

1.209 (g/cm2)

1.33
1.15

0.08
0.05

High
Low

1.6
1.8

1.2
1.4

0.58

VO2max

50.1 (ml/kg/min)

58.4
41.9

6.4
6.1

High
Low

2.1
1.4

1.4
1.2

0.07
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Table 3.B t-test results for the male group
Median
Mean
SD
35.20%
6.40%
BF% 26.10%
22.10%
2.80%
BMI

21.8

BMD 1.158 (g/cm2 )

Group
High
Low

Methylation (%)
Mean
SD
1.2
0.8
2.6
1.5

p value
0.007*

24.4
20.5

1.7
1.1

High
Low

1.3
2.5

1
1.5

0.028*

1.21
1.11

0.05
0.04

High
Low

2.1
1.7

1.6
1.2

0.54

2.4
1.5
53.4
7
High
1.6
1.1
39.5
6.4
Low
*The % BF has significant differences in % GDM between the high and the low groups
* The BMI has significant differences in % GDM between the high and the low groups
VO2max
45.9 (ml/kg/min)

Table 3.C t-test results for the female group
Median
Mean
SD
28.70%
6.60%
BF%
18.70%
14.20%
3.60%

High
Low

Methylation (%)
Mean
SD
1.5
1.3
1.3
1.1

Group

0.14

p value
0.78

BMI

25.2

29.7
23.4

4.2
1

High
Low

1.73
1.06

1.27
1.07

0.15

BMD

1.326 (g/cm2 )

1.4
1.24

0.05
0.05

High
Low

1.5
1.3

1.3
1.1

0.8

61.8
46.4

5
6.2

High
Low

1.6
1.4

1.1
1.4

0.76

VO2max 53.7 (ml/kg/min)
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